RPT-Indian drugmaker Lupin eyeing US, emerging mkt buys
(Repeats story from Wednesday)
MUMBAI, May 14 (Reuters) - Indian drugmaker Lupin Ltd (LUPN.BO: Quote, Profile, Research) is looking for acquisitions in the United States and in emerging markets to expand its overseas operations, its chairman said on Wednesday.
Desh Bandhu Gupta said Mumbai-based Lupin, which bought a stake in a Japanese generic drugmaker last year, aimed to bolster its presence in the Middle East, Southeast Asia and Latin America through acquisitions of drug formulation companies.
"These markets are very rewarding and we are working on acquiring something ... It will happen this year itself," he told reporters, after releasing quarterly results that beat expectations and lifted its shares more than 4 percent.
Lupin is also hoping to clinch a brand in the United States, the largest drug market, by the end of the fiscal year, said Vinita Gupta, president of Lupin's U.S. unit.
"We want to build on our Suprax portfolio. We are looking at brands, or companies with brands, that will add $20-$25 million to revenue," she said. "Our focus is the paediatric market."
Suprax is the company's antibiotic brand in the United States.
Last year, Lupin acquired a majority stake in Japanese drugmaker Kyowa Pharmaceutical Industry Co Ltd and Gujarat-based Rubamin Laboratories Ltd, a maker of raw materials for bulk drugs on a contract manufacturing basis.
Lupin posted a net profit of 961 million rupees ($23 million) for the fiscal fourth quarter ended March, above analysts' expectations for 858.8 million. Continued...
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India during the Reuters India Investment Summit in Mumbai and Bangalore. Full Coverage | Blog
An icon bows to changing times
With his Playboy Enterprises in talks to be sold for about $300 million, the 83 year-old Hugh Hefner will be giving up control over the iconic adult entertainment empire he founded that was instrumental in shaping society's opinions on nudity, sex and free speech. Full Article





India
US
UK









